Dosage and administration
apply to underarms only
apply to underarms only
Drug Facts
Aluminum zirconium tetrachlorohydrex gly 15.4%
Antiperspirant
reduces underarm wetness
For external use only
Do not use on broken skin
Ask a doctor before use if you have kidney disease
Stop use if rash or irritation occurs
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
apply to underarms only
elaeis guineensis (palm) kernel oil, stearyl alcohol, cyclomethicone, C12-15 alkyl benzoate, PPG-14 butyl ether, hydrogenated castor oil, hydrogenated soybean oil, PEG-8 distearate, fragrance, hydrolyzed corn starch, behenyl alcohol
Call 1-800-228-7408
Dist. by:
COLGATE-PALMOLIVE COMPANY
New York, NY 10022
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aluminum zirconium tetrachlorohydrex gly | ACTIVE INGREDIENT | 8O386558JE | 2 | |
| Aluminum zirconium tetrachlorohydrex gly | ACTIVE MOIETY | 8O386558JE | 2 | |
| alkyl (C12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 2 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| Docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 2 | |
| Hydrogenated castor oil | INACTIVE INGREDIENT | ZF94AP8MEY | 2 | |
| Hydrogenated soybean oil | INACTIVE INGREDIENT | A2M91M918C | 2 | |
| Palm kernel oil | INACTIVE INGREDIENT | B0S90M0233 | 2 | |
| PEG-8 distearate | INACTIVE INGREDIENT | 7JNC8VN07M | 2 | |
| PPG-14 butyl ether | INACTIVE INGREDIENT | R199TJT95T | 2 | |
| Stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 35000-623 | 35000-623-23, 35000-623-14 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Aluminum zirconium tetrachlorohydrex gly | 8O386558JE | ACTIB |
| Palm kernel oil | B0S90M0233 | IACT |
| Stearyl alcohol | 2KR89I4H1Y | IACT |
| Cyclomethicone | NMQ347994Z | IACT |
| alkyl (C12-15) benzoate | A9EJ3J61HQ | IACT |
| PPG-14 butyl ether | R199TJT95T | IACT |
| Hydrogenated castor oil | ZF94AP8MEY | IACT |
| Hydrogenated soybean oil | A2M91M918C | IACT |
| PEG-8 distearate | 7JNC8VN07M | IACT |
| Docosanol | 9G1OE216XY | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, FOR SUSPENSION / ORAL | 17 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | AEROSOL, FOAM / TOPICAL | 37 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / TOPICAL | 162000 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | LIQUID / TOPICAL | 0.24 %w/w | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | LOTION / TOPICAL | 1140 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, EXTENDED RELEASE / ORAL | 410.82 mg | ||
| Hydrogenated soybean oil | HYDROGENATED SOYBEAN OIL | A2M91M918C | TABLET, COATED / ORAL | 3 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| Hydrogenated soybean oil | HYDROGENATED SOYBEAN OIL | A2M91M918C | CAPSULE / ORAL | 95 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| Hydrogenated soybean oil | HYDROGENATED SOYBEAN OIL | A2M91M918C | TABLET / ORAL | 13.5 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET / ORAL | 232 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET / SUBLINGUAL | 1.6 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, EXTENDED RELEASE / ORAL | 393 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | SUSPENSION / TOPICAL | 286 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, DELAYED RELEASE / ORAL | 1337 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUPPOSITORY / VAGINAL | 8.5 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / VAGINAL | 425 mg | ||
| Docosanol | DOCOSANOL | 9G1OE216XY | SOLUTION / TOPICAL | 1.1 %w/w | ||
| Hydrogenated soybean oil | HYDROGENATED SOYBEAN OIL | A2M91M918C | TABLET, EXTENDED RELEASE / ORAL | 96 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | TABLET, FILM COATED / ORAL | 17 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 7.6 %w/w | ||
| Docosanol | DOCOSANOL | 9G1OE216XY | AEROSOL, FOAM / TOPICAL | 1.1 %w/w | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE / ORAL | 405 mg | ||
| Hydrogenated castor oil | HYDROGENATED CASTOR OIL | ZF94AP8MEY | CAPSULE, DELAYED RELEASE / ORAL | 3.1 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 5.26 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 89792e66-a41a-4674-a102-32b57b8c2c34 | 79fe14d5-ca89-4d77-a302-284b5ec02f75 | 2019-10-30 | Warnings | 79fe14d5-ca89-4d77-a302-284b5ec02f75 |
Adverse event summaries are temporarily unavailable. Other product information remains available.